title: The effect of mannitol on intraoperative brain relaxation in patients undergoing supratentorial tumor surgery: study protocol for a randomized controlled trial.
abstract: BACKGROUND
  The risk of brain swelling after dural opening is high in patients with midline shift undergoing supratentorial tumor surgery. Brain swelling may result in increased intracranial pressure, impeded tumor exposure, and adverse outcomes. Mannitol is recommended as a first-line dehydration treatment to reduce brain edema and enable brain relaxation during neurosurgery. Research has indicated that mannitol enhanced brain relaxation in patients undergoing supratentorial tumor surgery; however, these results need further confirmation, and the optimal mannitol dose has not yet been established. We propose to examine whether different doses of 20% mannitol improve brain relaxation in a dose-dependent manner when administered at the time of incision. We will examine patients with preexisting mass effects and midline shift undergoing elective supratentorial brain tumor surgery.
  
  
  METHODS
  This is a single-center, randomized controlled, parallel group trial that will be carried out at Beijing Tiantan Hospital, Capital Medical University. Randomization will be achieved using a computer-generated table. The study will include 220 patients undergoing supratentorial tumor surgery whose preoperative computed tomography/magnetic resonance imaging results indicate a brain midline shift. Patients in group A, group B, and group C will receive dehydration treatment at incision with 20% mannitol solutions of 0.7, 1.0, and 1.4 g/kg, respectively, at a rate of 600 mL/h. The patients in the control group will not receive mannitol. The primary outcome is an improvement in intraoperative brain relaxation and dura tension after dehydration with mannitol. Secondary outcomes are postoperative outcomes and the incidence of mannitol side effects.
  
  
  CONCLUSIONS
  The aim of this study is to determine the optimal dose of 20% mannitol for intraoperative infusion. We will examine brain relaxation and outcome in patients undergoing supratentorial tumor surgery. If our results are positive, the study will indicate the optimal dose of mannitol to improve brain relaxation and avoid side effects during brain tumor surgery.
  
  
  BACKGROUND
  The study is registered with the registry website http://www.chictr.org with the registration number ChiCTRTRC13003984 (17 December 2013).
authors.forename: Yuming
authors.initials: Y
authors.lastname: Peng
authors.forename: Xiaoyuan
authors.initials: X
authors.lastname: Liu
authors.forename: Aidong
authors.initials: A
authors.lastname: Wang
authors.affiliation: Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University, No, 6, Tiantan Xili, Dongcheng District, Beijing, 100050, PR China. ruquan.han@gmail.com.
authors.forename: Ruquan
authors.initials: R
authors.lastname: Han
mesh_terms: D001929:Brain Edema / Q000175:diagnosis / Q000517:prevention & control*; D002681:China; D002985:Clinical Protocols; D003399:Craniotomy / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007262:Infusions, Intravenous; D007430:Intraoperative Care; D008279:Magnetic Resonance Imaging; D008353:Mannitol / Q000008:administration & dosage*; D011446:Prospective Studies; D012107:Research Design; D015173:Supratentorial Neoplasms / Q000175:diagnosis / Q000601:surgery*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D008353:Mannitol